Atlas Trials

Recurrent or Metastatic Cervical Cancer

9 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Recurrent or Metastatic Cervical Cancer

RecordFirmDate
Relacorilant and Nab-Paclitaxel in Recurrent or Metastatic Cervical Cancer (NCT07763496)ARCAGY/ GINECO GROUP2026-10-01
TTE Study of QL1706 in Recurrent/Metastatic Cervical Cancer (NCT07652983)Qilu Hospital of Shandong University2026-06-15
ASCERV Study: MRG003 Combined With QL1706 in Recurrent or Metastatic Cervical Cancer (NCT07542717)Second Affiliated Hospital, Zhejiang University, School of Medicine2026-04-10
A Phase II Trial of SHR-A1811 in HER2-Expressing Recurrent/Metastatic Cervical Cancer (NCT07051486)Jiangsu HengRui Medicine Co., Ltd.2025-10-11
SHR-A1811 Combination Regimen for the Treatment of Recurrent or Metastatic Cervical Cancer (NCT06859775)Suzhou Suncadia Biopharmaceuticals Co., Ltd.2025-04-25
A Prospective Real-world Study of Cadonilimab in Patients With Recurrent or Metastatic Cervical Cancer (NCT06155422)Gang Chen (101199)2023-11-30
A Study of SHR-1210± SHR-1020 Versus Chemotherapy in Patients With Recurrent or Metastatic Cervical Cancer (NCT04680988)Jiangsu HengRui Medicine Co., Ltd.2021-04-05
A Study of AK104（ an Anti-PD-1 and Anti-CTLA-4 Bispecific Antibody) in Recurrent or Metastatic Cervical Cancer (NCT04868708)Akeso2021-04-01
A Study of TQB2450 Injection in Subjects With PD-L1 Positive Recurrent or Metastatic Cervical Cancer (NCT04623333)Chia Tai Tianqing Pharmaceutical Group Co., Ltd.2020-11-30

Track Recurrent or Metastatic Cervical Cancer automatically

Every clearance here is in the API, with alerts when new ones post.